Judges Scientific PLC
LSE:JDG

Watchlist Manager
Judges Scientific PLC Logo
Judges Scientific PLC
LSE:JDG
Watchlist
Price: 11 708 GBX 0.5%
Updated: May 17, 2024

Cash Flow Statement

Cash Flow Statement
Judges Scientific PLC

Rotate your device to view
Cash Flow Statement
Currency: GBP
Dec-2004 Jun-2005 Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Operating Cash Flow
Net Income
(0)
(0)
0
0
0
0
1
1
1
1
1
1
1
0
2
0
(0)
2
1
2
2
(0)
1
2
1
3
5
7
9
11
12
10
9
11
13
10
13
9
10
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
1
1
0
1
1
3
4
3
5
6
5
7
7
6
6
5
5
5
4
4
4
4
5
5
5
6
11
15
15
Other Non-Cash Items
0
0
0
0
0
0
0
0
1
0
0
1
2
2
1
2
2
1
1
1
0
(0)
1
1
1
1
1
1
2
2
2
2
2
2
3
3
6
13
13
Cash Taxes Paid
0
0
0
1
0
(1)
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
0
(0)
0
2
3
2
2
2
2
2
2
2
3
5
Cash Interest Paid
0
0
0
1
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
0
0
1
1
1
0
0
0
1
1
1
2
3
3
Change in Working Capital
0
0
0
(0)
(1)
(1)
(1)
(0)
0
(0)
(0)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(4)
(4)
(2)
(1)
(2)
(2)
(2)
(2)
(1)
(1)
(2)
(3)
(2)
(2)
(3)
(2)
(3)
(1)
(7)
(12)
(12)
Cash from Operating Activities
(0)
N/A
(0)
-9%
0
N/A
0
+69%
0
-82%
0
-78%
0
+1 750%
1
+257%
2
+14%
1
-43%
2
+74%
2
+21%
1
-21%
2
+22%
3
+94%
3
-4%
5
+42%
5
+0%
4
-21%
5
+40%
6
+10%
5
-18%
7
+42%
7
+5%
5
-33%
7
+60%
11
+42%
12
+14%
13
+11%
15
+10%
17
+15%
14
-17%
12
-12%
15
+25%
17
+14%
17
+0%
22
+25%
24
+11%
27
+10%
Investing Cash Flow
Capital Expenditures
0
0
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(0)
(0)
(0)
(0)
(1)
(1)
(0)
(1)
(2)
(2)
(1)
(0)
(0)
(1)
(1)
(1)
(1)
1
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(7)
(6)
(3)
(6)
Other Items
(0)
(1)
(2)
(1)
(1)
(0)
0
0
0
(0)
(1)
(1)
(1)
(2)
(3)
(8)
(7)
(11)
(12)
(2)
(1)
(8)
(7)
(5)
(6)
(2)
(9)
(6)
(1)
0
0
(6)
(11)
(6)
(1)
(26)
(44)
(38)
(20)
Cash from Investing Activities
(0)
N/A
(1)
-346%
(2)
-99%
(1)
+36%
(1)
+40%
(0)
+73%
0
N/A
(0)
N/A
(1)
-115%
(1)
+10%
(1)
-121%
(2)
-39%
(1)
+18%
(2)
-82%
(4)
-48%
(8)
-131%
(8)
+7%
(13)
-67%
(14)
-8%
(3)
+81%
(1)
+73%
(8)
-1 016%
(8)
-2%
(6)
+21%
(7)
-13%
(3)
+58%
(8)
-157%
(7)
+9%
(1)
+79%
(1)
+61%
(1)
-115%
(8)
-523%
(13)
-60%
(7)
+47%
(3)
+50%
(33)
-891%
(51)
-52%
(41)
+19%
(26)
+37%
Financing Cash Flow
Net Issuance of Common Stock
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
3
3
0
8
8
0
0
0
0
0
0
0
1
(1)
(2)
(0)
(0)
(0)
(1)
(2)
0
0
0
0
Net Issuance of Debt
0
2
2
1
0
(0)
(0)
(0)
(1)
1
1
(0)
0
2
2
2
2
8
8
(2)
(3)
2
0
(1)
3
(1)
2
2
(3)
(3)
(2)
9
6
(5)
(5)
39
37
3
1
Cash Paid for Dividends
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(2)
(2)
(2)
(15)
(15)
(3)
(3)
(4)
0
(4)
(4)
(6)
Other
(0)
(1)
(1)
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(0)
0
0
0
(0)
(0)
(0)
0
0
0
(1)
(1)
(0)
(1)
(0)
(1)
(1)
(1)
(2)
(3)
(3)
Cash from Financing Activities
(0)
N/A
2
N/A
3
+19%
0
-85%
0
-2%
(0)
N/A
(1)
-45%
(0)
+76%
(0)
-62%
1
N/A
1
-5%
(0)
N/A
(0)
-140%
2
N/A
2
-24%
5
+213%
4
-7%
7
+55%
15
+114%
5
-67%
(4)
N/A
1
N/A
(1)
N/A
(3)
-150%
2
N/A
(1)
N/A
0
N/A
1
+304%
(7)
N/A
(8)
-14%
(17)
-119%
(7)
+56%
2
N/A
(10)
N/A
(11)
-10%
35
N/A
31
-9%
(5)
N/A
(8)
-63%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
(0)
0
(0)
(0)
0
0
0
0
(0)
Net Change in Cash
(0)
N/A
1
N/A
1
-21%
(0)
N/A
(0)
+30%
(1)
-76%
0
N/A
1
+922%
1
-23%
1
+32%
1
-2%
0
-82%
0
N/A
1
N/A
1
+3%
(0)
N/A
1
N/A
(1)
N/A
5
N/A
7
+59%
1
-85%
(2)
N/A
(3)
-39%
(2)
+12%
(1)
+73%
3
N/A
3
-7%
5
+96%
5
-7%
6
+27%
(2)
N/A
(1)
+15%
1
N/A
(2)
N/A
3
N/A
19
+551%
2
-87%
(22)
N/A
(7)
+67%
Free Cash Flow
Free Cash Flow
(0)
N/A
(0)
-9%
0
N/A
0
+68%
0
-87%
(0)
N/A
0
N/A
1
+129%
1
+17%
1
-14%
1
+93%
2
+19%
1
-25%
1
+2%
3
+127%
3
-1%
4
+34%
3
-31%
2
-39%
4
+182%
5
+22%
4
-19%
6
+35%
6
-3%
4
-40%
7
+92%
11
+69%
11
-3%
12
+12%
14
+13%
16
+11%
12
-21%
11
-11%
14
+29%
15
+4%
10
-30%
15
+50%
21
+38%
21
-3%

See Also

Discover More